Abstract
INTRODUCTION
 The irrational prescription of drugs is highly prevalent among patients suffering from skin diseases. Since it has a serious impact on health and economy, there is an urgent need to study drug utilization pattern in hospital settings. Therefore, this study aims to investigate drug utilization pattern and its cost analysis in Dermatology Out Patient Department in a tertiary care teaching hospital.
 MATERIAL AND METHODS
 A four-month, prospective, cross-sectional descriptive study was conducted from 10th February 2022 to 10th June 2022 in newly diagnosed cases attending Out Patient Department of dermatology at Universal College of Medical Sciences, Bhairahawa, Nepal. Ethical approval was obtained from the Institutional Review Committee (UCMS/IRC/037/22). Purposive consecutive sampling technique was used. The data were collected from patient cards and details were filled in predesigned proforma. The collected data were analyzed in Statistical Package for Social Sciences version 20.
 RESULTS
 A total of 601 prescriptions were scrutinized. The common skin condition found was eczema (9.98%) while the common classes of drugs prescribed were antifungals (31.94%). The number of drugs per prescription varied from one to five with an average of 3.11. It was observed that 3.95% of prescription was by generic names. The maximum of drugs (36.06%) was prescribed in tablet form. The percentage of antibiotics prescribed and drugs prescribed from the WHO Essential Drugs List were 12.31% and 27.88% respectively. The average cost per prescription calculated was 739.39 Nepali Rupees.
 CONCLUSION
 A drug utilization study can help to rationalize prescriptions, reduce errors, and improve cost-effective treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.